Individual Study / Adams et al.; Transl Vis Sci Technol. 2018

Home Monitoring of Retinal Sensitivity on a Tablet Devicein Intermediate Age-Related Macular Degeneration

Home Monitoring of Retinal Sensitivity on a Tablet Devicein Intermediate Age-Related Macular Degeneration

Initiatives -
We determine the feasibility of using a home-based tablet device tomonitor retinal sensitivity (RS) in intermediate age-related macular degeneration(iAMD), the benefits of weekly reminders, and the comparison with clinic-based. Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
Start Year
2018
End Year
2018
Funding
Supported by The National Health and MedicalResearch Council), Principal Research Fellowship(GNT1103013) and Early Career Fellowship(#1104985, ZW). The Centre for Eye ResearchAustralia (CERA) receives Operational InfrastructureSupport from the Victorian Government

Design

Study design
Patients' cohort

Marker Paper

Adams M, Ho CYD, Baglin E, et al. Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration. Transl Vis Sci Technol. 2018;7(5):32. Published 2018 Oct 29. doi:10.1167/tvst.7.5.32

PUBMED 30386684

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
38
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other

Timeline

Population

Of 38 participants (mean age, 70.3 years) with iAMD enrolled in the study. (iAMD) - intermediate age-related macular degeneration (iAMD).
Selection Criteria
Minimum age
50
Newborns
Twins
Ethnic Origin
Health Status
  • Exclusion criteria were late AMD in either eye; otherocular diseases that could have influenced retinalsensitivity, such as glaucoma, significant cataracts,corneal pathology, diabetes, uncontrolled hyperten-sion, amblyopia, neurological or systemic diseaseaffecting vision; or any medication known to affectretinal function. Participants also were excluded ifthey had any physical and/or mental impairmentpreventing them from participating in this study or aninability to sign a consent form

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Clinic patients

Number of participants

Number of participants
38
Number of participants with biosamples
Data Collection Event
A customized test for tablets was designed to measure RS (within central 28) in individuals with iAMD at weekly intervals in their home, with remote datacollection. Half of the participants were randomized to receive weekly test reminders.
Start Date
2018
End Date
2018
Data sources
  • Mobile data collection
    • Smartphone apps
    • Tablet/laptop